desipramine has been researched along with methyldopa in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 12 (42.86) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (14.29) | 29.6817 |
2010's | 12 (42.86) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Avdeef, A; Tam, KY | 1 |
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Ekins, S; Williams, AJ; Xu, JJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Clineschmidt, BV; Scriabine, A; Sweet, CS | 1 |
Dean, CR; Hamilton, CA; Polak, G; Porsius, AJ; Reid, JL; Zamboulis, C | 1 |
van Spanning, HW; van Zwieten, PA | 1 |
van Zwieten, PA | 1 |
Carlsson, A | 1 |
Jackson, DM | 1 |
Baldessarini, RJ; Karobath, M | 1 |
Ehinger, B; Falck, B | 1 |
Brown, RM; Lal, H | 1 |
Arias, L; Cavanaugh, JH; Mitchell, JR; Oates, JA | 1 |
Carlsson, A; Fuxe, K; Hökfelt, T | 1 |
Aebert, K | 1 |
2 review(s) available for desipramine and methyldopa
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Pseudo-transmitters.
Topics: Animals; Antihypertensive Agents; Cell Membrane; Central Nervous System; Chemical Phenomena; Chemistry; Desipramine; Metaraminol; Methyldopa; Mice; Myocardium; Neurons; Rats; Reserpine; Sympathetic Nervous System; Synaptic Transmission | 1969 |
1 trial(s) available for desipramine and methyldopa
Article | Year |
---|---|
The effects of desmethylimipramine on the pharmacological actions of alpha methyldopa in man.
Topics: Adult; Blood Pressure; Catecholamines; Desipramine; Heart Rate; Humans; Hypnotics and Sedatives; Kinetics; Male; Methyldopa; Salivation; Time Factors | 1979 |
25 other study(ies) available for desipramine and methyldopa
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Central noradrenergic control of blood pressure.
Topics: Adrenergic alpha-Agonists; Animals; Blood Pressure; Cats; Clonidine; Desipramine; Dogs; Drug Interactions; Hemodynamics; Hypertension; Methyldopa; Neurons; Norepinephrine; Rabbits; Rats; Receptors, Drug | 1976 |
The interaction between alpha-methyl-dopa and tricyclic antidepressants.
Topics: Animals; Antidepressive Agents, Tricyclic; Blood Pressure; Cats; Desipramine; Drug Interactions; Female; Imipramine; Male; Methyldopa | 1975 |
Interaction between centrally acting hypotensive drugs and tricyclic antidepressants.
Topics: Amphetamine; Animals; Antidepressive Agents, Tricyclic; Antihypertensive Agents; Benzimidazoles; Blood Pressure; Cats; Clonidine; Cocaine; Desipramine; Dioxanes; Drug Interactions; Ephedrine; Female; Male; Methyldopa; Piperidines; Reserpine | 1975 |
The effect of -phenethylamine upon spontaneous motor activity in mice: a dual effect on locomotor activity.
Topics: Animals; Desipramine; Dibenzocycloheptenes; Disulfiram; Equipment and Supplies; Injections, Intraperitoneal; Male; Methyldopa; Methyltyrosines; Methysergide; Mice; Motor Activity; Phenethylamines; Reserpine; Time Factors | 1972 |
Effects of L-DOPA and L-3-O-methyl-DOPA on uptake of (3H)L-methionine by synaptosomes.
Topics: Animals; Binding, Competitive; Biological Transport, Active; Brain; Centrifugation; Cocaine; Depression, Chemical; Desipramine; Dihydroxyphenylalanine; Dinitrophenols; In Vitro Techniques; Kinetics; Male; Methionine; Methyldopa; Mitochondria; Nerve Endings; Ouabain; Rats; Sodium; Synaptosomes; Temperature; Time Factors; Tritium | 1972 |
Cellular uptake of some amino acids and amines in vitro into rabbit and monkey anterior eye segment preparations.
Topics: 5-Hydroxytryptophan; Amino Acids; Animals; Biological Transport, Active; Capillaries; Ciliary Body; Cocaine; Desipramine; Dihydroxyphenylalanine; Dopamine; Epithelium; Formaldehyde; Haplorhini; In Vitro Techniques; Iris; Melanocytes; Methyldopa; Methyltyrosines; Microscopy, Fluorescence; Norepinephrine; Normetanephrine; Ouabain; Pilocarpine; Quaternary Ammonium Compounds; Rabbits | 1970 |
A possible relationship between catecholamines and acute toxicity of desipramine.
Topics: 5-Hydroxytryptophan; Animals; Catecholamines; Chlorpromazine; Desipramine; Dihydroxyphenylalanine; Disulfiram; Male; Methyldopa; Mice; Mortality; Phenylalanine; Reserpine | 1968 |
Guanethidine and related agents. 3. Antagonism by drugs which inhibit the norepinephrine pump in man.
Topics: Antidepressive Agents; Antihypertensive Agents; Blood Pressure; Desipramine; Drug Antagonism; Guanethidine; Humans; Hypertension; Methyldopa; Norepinephrine; Phentolamine; Pulse; Tyramine | 1970 |
Effect of desmethylimipramine, protriptyline and (+)-amphetamine on fluorescence of central adrenergic neurons of rats pretreated with alpha-methyl-DOPA and tetrabenazine or reserpine.
Topics: Amphetamine; Animals; Antidepressive Agents; Behavior, Animal; Brain; Desipramine; Fluorescence; Histocytochemistry; Male; Methyldopa; Microscopy, Fluorescence; Mixed Function Oxygenases; Norepinephrine; Normetanephrine; Rats; Reserpine; Sympathetic Nervous System; Tetrabenazine | 1967 |
[What success does L-Dopa have in the treatment of parkinsonian akinesia?].
Topics: Aged; Biperiden; Blood-Brain Barrier; Desipramine; Dihydroxyphenylalanine; Dopa Decarboxylase; Female; Humans; Infusions, Parenteral; Male; Methyldopa; Middle Aged; Parasympatholytics; Parkinson Disease | 1967 |